A cooperative circumstance has slowly been made among domestic and foreign pharmaceutical companies against the Real Transaction Drug Price Reduction
While the ‘second movement’ has been raised to delay and improve the ‘Real Transaction Drug Price Reduction,’ the Korea Pharmaceutical Manufacturers Association(KPMA) and the KRPIA(Korea Research-based Pharma Industry Association) seem to cooperate with each other. They have judged there is limit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
